Nevirapine Caffeine / Ergotamine 635

Clinical Bottom Line
Minimal data to guide interaction: weigh risks and benefits of using this combination
Drug 1
Drug 1 dose
200 mg daily x 2 weeks then 200 mg BID x 28 days
Drug 1 effect

No significant change

Drug 2 effect

Not studied (may decrease ergot levels)

Clinical Effects

Ergotamine levels may be decreased

Management

If coadministering, monitor for ergot efficacy

Import ID
635